期刊
AESTHETIC SURGERY JOURNAL
卷 41, 期 -, 页码 S69-S74出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/asj/sjab130
关键词
-
类别
资金
- Suneva Medical, Inc. (San Diego, CA, USA)
- Allergan Aesthetics, an Abbvie Company (Irvine, CA, USA)
Autologous fat grafting has a long history dating back to the late 19th century, with significant advancements in knowledge and techniques since then. Future directions in fat grafting may focus on optimizing current methods, expanding clinical indications, and selectively utilizing adipose graft components for various regenerative purposes.
One of the earliest reported cases of autologous fat grafting (AFG) was by Neuber in 1893 and consisted of the transfer of small lobules of fat from the upper arm for cicatrical depression of the face. He advocated the use of smaller grafts, noting that pieces larger than the size of a bean would form cysts. In 1895, Czerny excised a lumbar lipoma and transplanted it to the chest for breast reconstruction. Since these early reports, the knowledge base around AFG has expanded exponentially, as illustrated by the other papers within this special topic. As we embark on the next phase of AFG in the clinical setting, there are several directions which are near-clinical translation. This paper discusses future directions in fat grafting that build on optimization of our current techniques as clinical indications expand, such as supplementing purified lipoaspirate and the associated regulatory burden, or deconstructing adipose tissue to selectively use adipose graft components for a variety of regenerative indications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据